We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Sues Janssen for Claiming Superiority of Its Psoriasis Drug
Novartis Sues Janssen for Claiming Superiority of Its Psoriasis Drug
Novartis filed a lawsuit on Friday accusing Janssen of falsely claiming that its plaque psoriasis drug Tremfya (guselkumab) is superior to Novartis’ product, Cosentyx (secukinumab).